Tags

Type your tag names separated by a space and hit enter

Immunosuppression during the COVID-19 pandemic in neuromyelitis optica spectrum disorders patients: A new challenge.
Mult Scler Relat Disord. 2020 06; 41:102097.MS

Authors+Show Affiliations

Neuroimmunology Unit, Department of Neuroscience, Hospital Alemán, Av Pueyrredón 1640, C1118AAT Buenos Aires, Argentina. Electronic address: ecarnerocontentti@hospitalaleman.com.Department of Infectious Diseases, Hospital Francisco J. Muñiz, Faculty of Medicine, University of Buenos Aires, Buenos Aires, Argentina.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32278860

Citation

Carnero Contentti, Edgar, and Jorge Correa. "Immunosuppression During the COVID-19 Pandemic in Neuromyelitis Optica Spectrum Disorders Patients: a New Challenge." Multiple Sclerosis and Related Disorders, vol. 41, 2020, p. 102097.
Carnero Contentti E, Correa J. Immunosuppression during the COVID-19 pandemic in neuromyelitis optica spectrum disorders patients: A new challenge. Mult Scler Relat Disord. 2020;41:102097.
Carnero Contentti, E., & Correa, J. (2020). Immunosuppression during the COVID-19 pandemic in neuromyelitis optica spectrum disorders patients: A new challenge. Multiple Sclerosis and Related Disorders, 41, 102097. https://doi.org/10.1016/j.msard.2020.102097
Carnero Contentti E, Correa J. Immunosuppression During the COVID-19 Pandemic in Neuromyelitis Optica Spectrum Disorders Patients: a New Challenge. Mult Scler Relat Disord. 2020;41:102097. PubMed PMID: 32278860.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Immunosuppression during the COVID-19 pandemic in neuromyelitis optica spectrum disorders patients: A new challenge. AU - Carnero Contentti,Edgar, AU - Correa,Jorge, Y1 - 2020/04/05/ PY - 2020/04/02/received PY - 2020/04/03/accepted PY - 2020/4/13/pubmed PY - 2020/7/3/medline PY - 2020/4/13/entrez SP - 102097 EP - 102097 JF - Multiple sclerosis and related disorders JO - Mult Scler Relat Disord VL - 41 SN - 2211-0356 UR - https://www.unboundmedicine.com/medline/citation/32278860/Immunosuppression_during_the_COVID_19_pandemic_in_neuromyelitis_optica_spectrum_disorders_patients:_A_new_challenge_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S2211-0348(20)30174-7 DB - PRIME DP - Unbound Medicine ER -